ALDH1A1 and neoplasm: In tumor cells isolated from TNBC xenografts, targeting the nPKC-θ axis significantly reduced the expression of nuclear localized PKC-θ in addition to several key CSC-like mesenchymal markers including CSV, ABCB5, ALDH1, and CD133/1.